Researchers Submit Patent Application, "Minocycline Compounds For Biodefense", for Approval (USPTO 20240238315).

MLA

“Researchers Submit Patent Application, ‘Minocycline Compounds For Biodefense’, for Approval (USPTO 20240238315).” Pharma Business Week, Aug. 2024, p. 4494. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178772446&authtype=sso&custid=ns315887.

APA

Researchers Submit Patent Application, “Minocycline Compounds For Biodefense”, for Approval (USPTO 20240238315). (2024). Pharma Business Week, 4494.

Chicago

“Researchers Submit Patent Application, ‘Minocycline Compounds For Biodefense’, for Approval (USPTO 20240238315).” 2024. Pharma Business Week, August, 4494. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178772446&authtype=sso&custid=ns315887.